Stocksigma LogoStocksigma Logo

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 6,601 (-16.3% YoY | -17.2% QoQ) ■ EBITDA: 16.2 (Loss to Profit YoY | -81.9% QoQ) ■ EBITDA Margin (%): 0.2 (Loss to Profit YoY | -88 bps QoQ) ■

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Samrat Pharmachem Ltd · Outcome · 14 Nov 2026, 9:22 pm

Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 6,601 (-16.3% YoY | -17.2% QoQ) ■ EBITDA: 16.2 (Loss to Profit YoY | -81.9% QoQ) ■ EBITDA Margin (%): 0.2 (Loss to Profit YoY | -88 bps QoQ) ■ PAT: 44.1 (Loss to Profit YoY | -49.6% QoQ) ■ EPS (INR): 1.43 (Loss to Profit YoY | -49.6% QoQ)

Original exchange filing (PDF)

More announcements from Samrat Pharmachem Ltd

All Samrat Pharmachem Ltd announcements